Results 111 to 120 of about 21,592 (229)

Prevention of bone loss in paraplegics over 2 years with alendronate

open access: yes, 2004
To assess the effects of long-term treatment of bone loss with alendronate in a group of paraplegic men, 55 patients were evaluated in a prospective randomized controlled open label study that was 2 years in duration comparing alendronate and calcium ...
Guido A Zäch   +15 more
core   +1 more source

Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients

open access: yes, 1997
Prolonged corticosteroid administration, as often required in the treatment of sarcoidosis, increases the risk of osteoporosis and fracture. The aim of the present study was to evaluate the usefulness of alendronate, a third generation bisphosphonate, in
GENNARI C.   +13 more
core   +1 more source

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide

open access: yesJBMR Plus, 2019
Teriparatide, currently only available in brand form in the United States, is a costly drug approved for the treatment of postmenopausal osteoporotic women who are at high risk of fracture.
Takahiro Mori   +2 more
doaj   +1 more source

The effect of alendronate on bone architecture at P28 (*p<0.05).

open access: yes, 2014
Alendronate dose and group (Botox vs. Saline vs. Normal) significantly affected BV/TV, connectivity density, Tb.N, and Tb.Sp. At the highest dose of alendronate, Botox was significantly different than Normal for BV/TV and Tb.Sp.
Stavros Thomopoulos (299362)   +7 more
core   +1 more source

Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy

open access: yes, 2004
Low-dose alendronate is as effective as standard-dose alendronate, and its effects continue after drug withdrawal in postmenopausal osteoporotic women who are being treated with ...
T. Russo   +11 more
core   +1 more source

Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis

open access: yes, 2015
Diego dos Santos Ferreira,1 Fernanda Alves Boratto,1 Valbert Nascimento Cardoso,2 Rogéria Serakides,3 Simone Odília Fernandes,2 Lucas Antônio Miranda Ferreira,1 Mônica Cristina Oliveira1 1Department of Pharmaceutical Products ...
Cardoso VN   +6 more
core  

Improved dosage form of the combined alendronate and calcitriol (Maxmarvil®) on the absorption of alendronate in Korean postmenopausal women.

open access: yes, 2013
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. However, high doses of alendronate cause esophageal irritation, myalgia, gastrointestinal discomfort and decrease of serum calcium level. Recently, Maxmarvil®
Chung, YS, Choi, YJ, Kim, SH
core   +1 more source

Comparative Molecular Docking, Molecular Dynamics and Adsorption–Release Analysis of Calcium Fructoborate and Alendronate Salts on Hydroxyapatite and Hydroxyapatite–Titanium Implants

open access: yesBiomedicines
Background/Objectives: Hydroxyapatite (HAp)-based implants and HAp–titanium (HApTi) composites are widely used in orthopedic and dental applications, but their long-term success is limited by peri-implant bone loss.
Diana-Maria Trasca   +6 more
doaj   +1 more source

Octreotide ameliorates alendronate-induced gastric injury

open access: yes, 2004
Alendronate causes serious gastrointestinal adverse effects. The aim of this study was to investigate whether octreotide, a synthetic somatostatin analogue, improves the alendronate-induced gastric injury.
ELÇİOĞLU, HATİCE KÜBRA   +7 more
core   +1 more source

Alendronate as Bioactive Coating on Titanium Surfaces: An Investigation of CaP–Alendronate Interactions

open access: yesMaterials
The surface modification of dental implants plays an important role in establishing a successful interaction of the implant with the surrounding tissue, as the bioactivity and osseointegration properties are strongly dependent on the physicochemical properties of the implant surface.
Ines Despotović   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy